Key Details
Price
$0.49Annual ROE
-187.61%Beta
1.55Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 6, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Nov 27, 24 Mizuho
OutperformNov 19, 24 HC Wainwright & Co.
BuyNov 15, 24 Guggenheim
BuyNov 14, 24 HC Wainwright & Co.
BuyAug 13, 24 HC Wainwright & Co.
BuyAug 5, 24 HC Wainwright & Co.
BuyJul 30, 24 HC Wainwright & Co.
BuyMay 30, 24 Scotiabank
Sector OutperformMay 17, 24 Mizuho
BuyAug 10, 23 EF Hutton
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Adaptimmune Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Adaptimmune Therapeutics?
- Does Adaptimmune Therapeutics pay dividends?
- What sector is Adaptimmune Therapeutics in?
- What industry is Adaptimmune Therapeutics in?
- What country is Adaptimmune Therapeutics based in?
- When did Adaptimmune Therapeutics go public?
- Is Adaptimmune Therapeutics in the S&P 500?
- Is Adaptimmune Therapeutics in the NASDAQ 100?
- Is Adaptimmune Therapeutics in the Dow Jones?
- When was Adaptimmune Therapeutics's last earnings report?
- When does Adaptimmune Therapeutics report earnings?
- Should I buy Adaptimmune Therapeutics stock now?
What is the ticker symbol for Adaptimmune Therapeutics?
The ticker symbol for Adaptimmune Therapeutics is NASDAQ:ADAP
Does Adaptimmune Therapeutics pay dividends?
No, Adaptimmune Therapeutics does not pay dividends
What sector is Adaptimmune Therapeutics in?
Adaptimmune Therapeutics is in the Healthcare sector
What industry is Adaptimmune Therapeutics in?
Adaptimmune Therapeutics is in the Biotechnology industry
What country is Adaptimmune Therapeutics based in?
Adaptimmune Therapeutics is headquartered in United Kingdom
When did Adaptimmune Therapeutics go public?
Adaptimmune Therapeutics's initial public offering (IPO) was on May 6, 2015
Is Adaptimmune Therapeutics in the S&P 500?
No, Adaptimmune Therapeutics is not included in the S&P 500 index
Is Adaptimmune Therapeutics in the NASDAQ 100?
No, Adaptimmune Therapeutics is not included in the NASDAQ 100 index
Is Adaptimmune Therapeutics in the Dow Jones?
No, Adaptimmune Therapeutics is not included in the Dow Jones index
When was Adaptimmune Therapeutics's last earnings report?
Adaptimmune Therapeutics's most recent earnings report was on Nov 13, 2024
When does Adaptimmune Therapeutics report earnings?
The next expected earnings date for Adaptimmune Therapeutics is Mar 13, 2025
Should I buy Adaptimmune Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions